Townsquare Capital LLC Cv Rx, Inc. Transaction History

Townsquare Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$11.67 - $33.01 $280,920 - $794,616	-24,072 Reduced 76.77%	7,283 $228,000
Q3 2023 Nov 15, 2023	SELL	$13.56 - $18.47 $58,619 - $79,845	-4,323 Reduced 12.12%	31,355 $475,000
Q2 2023 Nov 13, 2023	SELL	$8.57 - $15.44 $38,864 - $70,020	-4,535 Reduced 11.28%	35,678 $550,000
Q1 2023 May 11, 2023	BUY	$7.08 - $19.4 $137,564 - $376,942	19,430 Added 93.49%	40,213 $374,000
Q4 2022 Feb 13, 2023	BUY	$8.94 - $18.35 $185,800 - $381,368	20,783 New	20,783 $381,000

14.4M

56.3K

41.8K

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $355M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.